CK1-α is a component of the beta (β)-catenin destruction complex and a negative regulator of p53, and several studies [15, 48] recently reported that reduced CK1-α levels decrease MM cell survival and inhibit cell cycle progression [15, 48]. This evidence concerns the gene TP53 and Miyoshi myopathy.